13F filer · CIK 1103804 ↗
Viking Global
You are looking at Q3 2022. See the latest, Q2 2026 →
Reported value
$21.66B
−0.9% on the quarter before
Positions
88
20 new · 14 sold out
Top 10
37.7%
of the value
Est. gain
−$280.2M
on stocks held all quarter
Est. return
−1.7%
on those stocks since Q2 2022
Positions as of Sep 30, 2022, from Viking Global's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q2 2022. Striped tiles are options.
Largest buys
Since Q2 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Visa Inc.~$495.8MAdded · 2.3% → 4.4%+2,790,724 shares
- Elevance Health Inc~$396.3MAdded · 3.2% → 4.9%+872,356 shares
- Salesforce~$345.3MNew · 0.0% → 1.6%+2,400,649 shares
- Meta~$337.3MAdded · 2.1% → 3.4%+2,485,635 shares
- Mckesson Corp~$334.1MAdded · 2.4% → 4.1%+983,065 shares
- Dollar Gen Corp New~$315.7MAdded · 1.2% → 2.7%+1,316,194 shares
- General Electric Co~$255.3MAdded · 2.5% → 3.7%+4,123,843 shares
- Ginkgo Bioworks Holdings Inc~$233.2MAdded · 0.3% → 1.5%+74,750,000 shares
- Micron~$197.6MAdded · 0.4% → 1.3%+3,943,315 shares
- Western Digital~$176.9MAdded · 0.4% → 1.1%+5,434,370 shares
Largest sells
Since Q2 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- T-Mobile Us Inc~$784.3MCut · 5.6% → 2.1%−5,845,787 shares
- Centene Corp Del~$701.7MSold out · 3.2% → 0.0%−8,293,867 shares
- American Intl Group Inc~$516.9MSold out · 2.4% → 0.0%−10,108,715 shares
- Fortive Corp~$333.6MCut · 2.9% → 1.6%−5,722,754 shares
- Parker-Hannifin Corp~$313.8MCut · 3.5% → 2.0%−1,295,238 shares
- Lam Research~$295.8MSold out · 1.4% → 0.0%−694,026 shares
- Marsh & Mclennan Cos Inc~$272.0MCut · 2.0% → 0.7%−1,821,705 shares
- Boeing Co~$190.2MSold out · 0.9% → 0.0%−1,391,238 shares
- Aon Plc~$190.0MSold out · 0.9% → 0.0%−704,639 shares
- Walt Disney Company (The)~$164.4MSold out · 0.8% → 0.0%−1,741,500 shares
Holdings
As of Sep 30, 2022. Changes are in shares against Jun 30, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Elevance Health IncCOM · shares +60% · price −5.9% | 4.9% | $1.06B | −$41.5M | ||||||||
| AmazonCOM · shares +15% · price +6.4% | 4.8% | $1.05B | +$55.0M | ||||||||
| Visa Inc.COM CL A · shares +109% · price −9.8% | 4.4% | $949.8M | −$49.2M | ||||||||
| Mckesson CorpCOM · shares +60% · price +4.2% | 4.1% | $886.6M | +$22.2M | ||||||||
| MicrosoftCOM · shares +18% · price −9.3% | 3.8% | $817.6M | −$70.9M | ||||||||
| General Electric CoCOM NEW · shares +47% · price −2.8% | 3.7% | $797.0M | −$15.4M | ||||||||
| MetaCL A · shares +87% · price −15.9% | 3.4% | $726.1M | −$73.3M | ||||||||
| Chubb LimitedCOM · shares −4.8% · price −7.5% | 3.0% | $653.5M | −$52.8M | ||||||||
| Boston Scientific CorpCOM · shares +10% · price +3.9% | 2.9% | $626.0M | +$21.4M | ||||||||
| Brookfield Asset Mgmt IncCL A LTD VT SH · shares +22% · price −8.1% | 2.8% | $603.4M | −$43.4M | ||||||||
| Dollar Gen Corp NewCOM · shares +119% · price −2.3% | 2.7% | $582.0M | −$6.2M | ||||||||
| Hdfc Bank LtdSPONSORED ADS · shares +5.8% · price +6.3% | 2.6% | $567.5M | +$31.8M | ||||||||
| MastercardCL A · shares −23% · price −9.9% | 2.3% | $503.4M | −$55.1M | ||||||||
| Ameriprise Finl IncCOM · shares +52% · price +6.0% | 2.1% | $454.5M | +$16.9M | ||||||||
| Api Group CorpCOM STK · shares +0.5% · price −11.4% | 2.1% | $448.8M | −$57.2M | ||||||||
| IntuitCOM · shares +3.8% · price +0.5% | 2.1% | $448.3M | +$2.1M | ||||||||
| T-Mobile Us IncCOM · shares −64% · price −0.3% | 2.1% | $446.1M | −$1.2M | ||||||||
| Royalty Pharma PlcSHS CLASS A · shares −12% · price −4.4% | 2.0% | $437.2M | −$20.2M | ||||||||
| UberCOM · shares −1.1% · price +29.5% | 2.0% | $434.5M | +$99.0M | ||||||||
| Biomarin Pharmaceutical IncCOM · shares +0.9% · price +2.3% | 2.0% | $432.3M | +$9.6M | ||||||||
| Parker-Hannifin CorpCOM · shares −42% · price −1.5% | 2.0% | $430.2M | −$6.6M | ||||||||
| Fortive CorpCOM · shares −49% · price +7.2% | 1.6% | $354.2M | +$23.8M | ||||||||
| SalesforceCOM · shares New | 1.6% | $345.3M | — | ||||||||
| International Flavors&FragraCOM · shares −27% · price −23.7% | 1.6% | $338.5M | −$105.4M | ||||||||
| Ginkgo Bioworks Holdings IncCL A SHS · shares +276% · price +31.1% | 1.5% | $317.7M | +$20.0M | ||||||||
| Total · 88 positions | 100% | $21.66B | −$280.2M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2022 to Q3 2022: 67 stocks held throughout, down $280.2M (−1.7%).
- Karuna Therapeutics Inc+$99.8M+78%
- Uber+$99.0M+30%
- Amazon+$55.0M+6%
- Guardant Health Inc+$51.7M+33%
- Amylyx Pharmaceuticals Inc+$51.3M+46%
- Catalent Inc−$58.5M−33%
- Microsoft−$70.9M−9%
- Meta−$73.3M−16%
- Roivant Sciences Ltd−$75.0M−21%
- International Flavors&Fragra−$105.4M−24%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $35.08B−2% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $35.75B−5% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $37.68B−2% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $38.50B+11% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $34.59B+10% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $31.48B+2% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $30.90B+13% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $27.44B+5% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $26.02B−3% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $26.86B−2% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $27.30B+11% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $24.64B+1% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $24.43B+15% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $21.31B+7% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $19.98B−8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $21.66B−1% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $21.86B−12% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $24.74B−29% | SEC ↗ |
| Q4 2021 | May 16, 2022 (amended) | $34.71B−5% | SEC ↗ |
| Q3 2021 | May 16, 2022 (amended) | $36.46B+11% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $32.98B−2% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $33.58B−8% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $36.37B+31% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $27.68B+20% | SEC ↗ |
| Q2 2020 | Aug 7, 2020 | $23.14B+20% | SEC ↗ |
| Q1 2020 | May 13, 2020 | $19.21B−10% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $21.35B+11% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $19.20B−14% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $22.29B+28% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $17.44B−1% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $17.57B−3% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $18.06B+3% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $17.47B+5% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $16.61B+2% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $16.26B+5% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $15.44B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $14.85B−34% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $22.64B+3% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $22.01B−5% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $23.18B−2% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $23.54B+4% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $22.72B | SEC ↗ |